Global /China /Healthcare /Pharmaceutical Retailers /603233

DaShenLin Pharmaceutical Group Co., Ltd.

603233

• SSE: 603233 • Delayed

18.72CNY -3.3%

2.77 USD

As of 5 June 2026, DaShenLin Pharmaceutical Group Co., Ltd. has a market cap of $3.26B USD, ranking #5149 globally and #1085 in China. It ranks #401 in the Healthcare sector, and #11 in the Pharmaceutical Retailers industry.

Global Rank

5149

Country Rank

1085

Sector Rank

401

Industry Rank

Key Stats

Market Cap

$3.26BUSD

22.04B CNY

Enterprise Value

$3.16BUSD

21.4B CNY

Revenue (TTM)

$4.07BUSD

27.52B CNY

EBITDA (TTM)

$310.25MUSD

2.1B CNY

Net Income (TTM)

$190.09MUSD

1.29B CNY

EBITDA Margin

7.6%

Profit Margin

4.7%

PE Ratio

17.2

Forward PE

16.1

PS Ratio

0.8

PB Ratio

2.4

EV/EBITDA

9.8

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Pharmaceutical Retailers

CEO

Guoqiang Ke open_in_new

Employees

43,532

Founded

1999

Website

dslyy.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.3%	8.8%	10%	-2.3%	6.1%	9.8%	9%	-33%	-56%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603233 大参林医药集团股份有限公司 Class A ISIN: CNE100002RG2 Shares Out.: Shares Outstanding: 1.132B¹ Shares Float: 376.048M² TV: TradingView: SSE: 603233 SA: Stock Analysis: SHA: 603233 YF: Yahoo Finance: 603233.SS GF: Google Finance: SHA: 603233 BA: Barron's: 603233 MS: Morningstar: XSHG: 603233	18.72 CNY	TV: TradingView: SSE: 603233 SA: Stock Analysis: SHA: 603233 YF: Yahoo Finance: 603233.SS GF: Google Finance: SHA: 603233 BA: Barron's: 603233 MS: Morningstar: XSHG: 603233

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About DaShenLin Pharmaceutical Group Co., Ltd.

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

Similar Companies

Industry: Pharmaceutical Retailers (China)

Name	Market Cap (USD) diff.	PE	Country
JD Health International Inc. SHEK: 6618	$18.58B 145.64B HKD 471%	24.3	China
Yifeng Pharmacy Chain Co., Ltd. SSE: 603939	$4.16B 28.13B CNY 28%	16.6	China
LBX Pharmacy Chain Joint Stock Co. SSE: 603883	$1.58B 10.71B CNY -51%	27.2	China
Anhui Huaren Health Pharmaceutical Co., Ltd. SHE: 301408	$1.24B 8.4B CNY -62%	39.9	China
Yixintang Pharmaceutical Group Co., Ltd. SHE: 002727	$1.08B 7.32B CNY -67%	26.3	China
Beijing Konruns Pharmaceutical Co.,Ltd. SSE: 603590	$852.01M 5.77B CNY -74%	34.2	China

Industry: Pharmaceutical Retailers (Global)

Name	Market Cap (USD) diff.	PE	Country
CVS Health Corp. NYSE: CVS	$107.53B 3K%	58.3	United States
Walgreens Boots Alliance, Inc. NASDAQ: WBA	$10.37B 218%	-	United States
Raia Drogasil S.A. BVMF: RADL3	$7.61B 38.53B BRL 134%	28.2	Brazil
Tsuruha Holdings Inc. TSE: 3391	$6.09B 974.65B JPY 87%	14.9	Japan
MatsukiyoCocokara & Co. TSE: 3088	$5.9B 944.48B JPY 81%	16.9	Japan
Welcia Holdings Co., Ltd. TSE: 3141	$4.11B 657.73B JPY 26%	34.2	Japan

chevron_leftBack